New evidence
Curcumin tied to a 25.8-point improvement in quality-of-life scores for ulcerative colitis patients — but the analysis pools few trials and no dose is specified.
This network meta-analysis offers some of the first pooled evidence that curcumin may help improve quality of life in ulcerative colitis, but the result comes from a small number of included studies and should be treated as preliminary rather than definitive.
A network meta-analysis of 24 randomized trials with 491 ulcerative colitis patients found that curcumin was associated with a significant 25.8-point increase on the Inflammatory Bowel Disease Questionnaire compared to conventional treatment or placebo, indicating better quality of life. The analysis also found that other supplements like probiotics and selenium helped reduce symptoms, while flaxseed, butyrate, and curcumin improved quality of life. However, the evidence is still early and more consistent research is needed before drawing firm conclusions.
Where this fits in the evidence
This is among the first studies we've indexed on Resveratrol for Improved Inflammatory Bowelayed Inflammatory Bowel Disease Questionnaire Score — treat it as an early signal until more research accumulates.
The study
- Systematic Review
- n = 491
- 2026-04-22
- Frontiers in medicine
More on ResveratrolMore on Improved Inflammatory Bowelayed Inflammatory Bowel Disease Questionnaire Score
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.